Skip to main navigation Skip to search Skip to main content

A Current Overview of Next-Generation Probiotics and Their Prospects in Health and Disease Management

    Research output: Journal PublicationReview articlepeer-review

    19 Citations (Scopus)

    Abstract

    Traditional probiotics have been extensively studied, and their effectiveness in gut modulation is well established. However, emerging research has shifted focus to previously understudied probiotic strains, now known as next-generation probiotics (NGPs), with the aim of harnessing their unique potential to elicit targeted therapeutic effects in disease management. This study aims to provide a comprehensive review on the recent evidence on NGPs by exploring their potential roles and applications in human health and agricultural settings. The literature search was conducted systematically across four databases with the keywords “next generation probiotics” and “gut health” or treatment” or “therapy”. The findings of this review identified promising NGPs, including Akkermansia muciniphila, Bacillus sp., Bacteroides sp., Enterococcus sp., Faecalibacterium sp., Parabacteroides sp., and Streptomyces sp. These NGPs can elicit targeted effects in specific disease states while simultaneously restore gut dysbiosis by promoting beneficial bacteria, elevated short-chain fatty acid levels, and stimulate immunomodulatory effects to reduce inflammation. These modes of action are closely linked to one another, acting as a positive feedback loop to reduce inflammation in the host. Besides, other niche NGPs that are lesser-studied also show therapeutic effects in disease management, highlighting the importance of further research into these species to uncover potential mechanistic pathways for treating various illnesses. In summary, NGPs can offer targeted therapeutic effects in addition to probiotic effects in the gut, providing a multi-faceted approach in treating various health conditions. The development of therapeutics with these NGPs could offer alternatives to current treatment strategies to improve disease outcomes and prognosis. Nevertheless, future research is essential to better elucidate the exact mechanisms, safety profiles, and therapeutic applications of these NGPs.

    Original languageEnglish
    Article numbera0000457
    JournalProgress in Microbes and Molecular Biology
    Volume7
    Issue number1
    DOIs
    Publication statusPublished - 2024

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Free Keywords

    • agriculture
    • gut health
    • gut modulation
    • life biotherapeutics
    • microbiota
    • next-generation probiotics
    • SDG 3 Good health and well-being

    ASJC Scopus subject areas

    • Microbiology
    • Molecular Biology
    • Biochemistry, Genetics and Molecular Biology (miscellaneous)
    • Microbiology (medical)

    Fingerprint

    Dive into the research topics of 'A Current Overview of Next-Generation Probiotics and Their Prospects in Health and Disease Management'. Together they form a unique fingerprint.

    Cite this